tetano
Editor, Senior Moderator
Ann Lab Med
. 2023 Dec 13.
doi: 10.3343/alm.2023.0256. Online ahead of print. Neutralization Testing-based Immunogenicity Analysis of Recent Prevalent Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Sublineages
Eun Ju Lee[SUP] 1 2 [/SUP], Hyeokjin Lee[SUP] 1 [/SUP], Sang Won O[SUP] 1 [/SUP], Jee Eun Rhee[SUP] 1 [/SUP], Jeong-Min Kim[SUP] 1 [/SUP], Dong Ju Kim[SUP] 1 [/SUP], Il-Hwan Kim[SUP] 1 [/SUP], Jin Sun No[SUP] 1 [/SUP], Ae Kyung Park[SUP] 1 [/SUP], Jeong-Ah Kim[SUP] 1 [/SUP], Chae Young Lee[SUP] 1 [/SUP], Young-Ki Choi[SUP] 2 [/SUP], Eun-Jin Kim[SUP] 1 [/SUP]
Affiliations
Although WHO declared the end of the public health emergency for coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), XBB lineages continue to evolve and emerge globally. In particular, XBB.1.5 and XBB.1.16 are raising concerns because of their high immune evasion, leading to apprehensions regarding vaccine efficacy reduction and potential reinfection. We aimed to investigate the COVID-19 outbreak in Korea and predict the likelihood of reinfection by testing neutralizing activity against live viruses from the S clade and 19 Omicron sublineages. We found a significant risk of infection with the currently prevalent XBB lineage for individuals who were either vaccinated early or infected during the initial Omicron outbreak. Vaccinated individuals were better equipped than unvaccinated individuals to produce neutralizing antibodies for other SARS-CoV-2 variants upon infection. Therefore, unvaccinated individuals do not easily develop neutralizing activity against other variants and face the highest risk of reinfection by the XBB lineage. Our study provides important information to facilitate the development of strategies for monitoring populations that would be the most susceptible to new COVID-19 outbreaks.
Keywords: Disease outbreaks; Neutralization antibodies; Omicron; Reinfection; SARS-CoV-2.
. 2023 Dec 13.
doi: 10.3343/alm.2023.0256. Online ahead of print. Neutralization Testing-based Immunogenicity Analysis of Recent Prevalent Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Sublineages
Eun Ju Lee[SUP] 1 2 [/SUP], Hyeokjin Lee[SUP] 1 [/SUP], Sang Won O[SUP] 1 [/SUP], Jee Eun Rhee[SUP] 1 [/SUP], Jeong-Min Kim[SUP] 1 [/SUP], Dong Ju Kim[SUP] 1 [/SUP], Il-Hwan Kim[SUP] 1 [/SUP], Jin Sun No[SUP] 1 [/SUP], Ae Kyung Park[SUP] 1 [/SUP], Jeong-Ah Kim[SUP] 1 [/SUP], Chae Young Lee[SUP] 1 [/SUP], Young-Ki Choi[SUP] 2 [/SUP], Eun-Jin Kim[SUP] 1 [/SUP]
Affiliations
- PMID: 38087945
- DOI: 10.3343/alm.2023.0256
Although WHO declared the end of the public health emergency for coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), XBB lineages continue to evolve and emerge globally. In particular, XBB.1.5 and XBB.1.16 are raising concerns because of their high immune evasion, leading to apprehensions regarding vaccine efficacy reduction and potential reinfection. We aimed to investigate the COVID-19 outbreak in Korea and predict the likelihood of reinfection by testing neutralizing activity against live viruses from the S clade and 19 Omicron sublineages. We found a significant risk of infection with the currently prevalent XBB lineage for individuals who were either vaccinated early or infected during the initial Omicron outbreak. Vaccinated individuals were better equipped than unvaccinated individuals to produce neutralizing antibodies for other SARS-CoV-2 variants upon infection. Therefore, unvaccinated individuals do not easily develop neutralizing activity against other variants and face the highest risk of reinfection by the XBB lineage. Our study provides important information to facilitate the development of strategies for monitoring populations that would be the most susceptible to new COVID-19 outbreaks.
Keywords: Disease outbreaks; Neutralization antibodies; Omicron; Reinfection; SARS-CoV-2.